Access the full text.
Sign up today, get DeepDyve free for 14 days.
L. Rubin, J. Staddon (1999)The cell biology of the blood-brain barrier.
Annual review of neuroscience, 22
S. Byfield, C. Major, N. Laping, A. Roberts (2004)SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7.
Molecular pharmacology, 65 3
H. Günther, N. Schmidt, H. Phillips, D. Kemming, S. Kharbanda, R. Soriano, Z. Modrušan, H. Meissner, M. Westphal, K. Lamszus (2008)Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria
W. Jong, P. Borm (2008)Drug delivery and nanoparticles: Applications and hazards
International Journal of Nanomedicine, 3
S. Bigner, J. Mark, P. Burger, M. Mahaley, D. Bullard, L. Muhlbaier, D. Bigner (1988)Specific chromosomal abnormalities in malignant human gliomas.
Cancer research, 48 2
S. Bao, Qiulian Wu, R. McLendon, Y. Hao, Q. Shi, A. Hjelmeland, M. Dewhirst, D. Bigner, J. Rich (2006)Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Kamna Aggarwal, J. Massagué (2012)Ubiquitin removal in the TGF-β pathway
Nature Cell Biology, 14
R. Jensen (1998)Growth factor-mediated angiogenesis in the malignant progression of glial tumors: a review.
Surgical neurology, 49 2
B. Kamińska, A. Wesolowska, Malgorzata Danilkiewicz (2005)TGF beta signalling and its role in tumour pathogenesis.
Acta biochimica Polonica, 52 2
Yabing Mu, Shyam Gudey, M. Landström (2011)Non-Smad signaling pathways
Cell and Tissue Research, 347
M. Boeck, P. Dijke (2012)Key role for ubiquitin protein modification in TGFβ signal transduction
Upsala Journal of Medical Sciences, 117
H-s Nam, R Benezra (2009)High levels of Id1 expression define B1 type adult neural stem cells
Stem Cell, 5
J. Seoane, Hong-Van Le, Lijian Shen, S. Anderson, J. Massagué (2004)Integration of Smad and Forkhead Pathways in the Control of Neuroepithelial and Glioblastoma Cell Proliferation
J. Uhm, C. Gladson, J. Rao (1999)The role of integrins in the malignant phenotype of gliomas.
Frontiers in bioscience : a journal and virtual library, 4
R. Derynck (1994)TGF-β-receptor-mediated signaling
Trends in Biochemical Sciences, 19
H Fakhrai, O Dorigo, DL Shawler (1996)Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy
Proc Natl Acad Sci U S A, 93
I. Matsuura, N. Denissova, Guannan Wang, Dongming He, Jianyin Long, Fang Liu (2004)Cyclin-dependent kinases regulate the antiproliferative function of Smads
M. Gadji, D. Fortin, A. Tsanaclis, Y. Garini, Nir Katzir, Yifat Wienburg, Ju Yan, L. Klewes, T. Klonisch, R. Drouin, S. Mai (2010)Three-dimensional nuclear telomere architecture is associated with differential time to progression and overall survival in glioblastoma patients.
Neoplasia, 12 2
Sherif Louis, B. Vermolen, Y. Garini, I. Young, Amanda Guffei, Zelda Lichtensztejn, F. Kuttler, T. Chuang, S. Moshir, V. Mougey, A. Chuang, P. Kerr, T. Fest, P. Boukamp, S. Mai (2005)c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus.
Proceedings of the National Academy of Sciences of the United States of America, 102 27
J. Godlewski, M. Nowicki, A. Bronisz, Shante Williams, Akihiro Otsuki, G. Nuovo, A. Raychaudhury, H. Newton, E. Chiocca, S. Lawler (2008)Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal.
Cancer research, 68 22
S. Peñuelas, J. Anido, Rosa Prieto-Sánchez, Gerard Folch, I. Barba, I. Cuartas, D. Garcia-Dorado, M. Poca, J. Sahuquillo, J. Sahuquillo, J. Baselga, J. Baselga, J. Seoane (2009)TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma.
Cancer cell, 15 4
J. Saharinen, Marko Hyytiäinen, J. Taipale, J. Keski‐oja (1999)Latent transforming growth factor-beta binding proteins (LTBPs)--structural extracellular matrix proteins for targeting TGF-beta action.
Cytokine & growth factor reviews, 10 2
S. Abdollah, M. Macías-Silva, T. Tsukazaki, H. Hayashi, L. Attisano, J. Wrana (1997)TβRI Phosphorylation of Smad2 on Ser465 and Ser467 Is Required for Smad2-Smad4 Complex Formation and Signaling*
The Journal of Biological Chemistry, 272
C. Dubois, M. Laprise, F. Blanchette, L. Gentry, R. Leduc (1995)Processing of Transforming Growth Factor 1 Precursor by Human Furin Convertase (*)
The Journal of Biological Chemistry, 270
Julie Basque, M. Martel, R. Leduc, A. Cantin (2008)Lysosomotropic drugs inhibit maturation of transforming growth factor-beta.
Canadian journal of physiology and pharmacology, 86 9
D. Fortin, A. Desjardins, Andrew Benko, Theophylle Niyonsega, M. Boudrias (2005)Enhanced chemotherapy delivery by intraarterial infusion and blood‐brain barrier disruption in malignant brain tumors
A. Molofsky, R. Pardal, T. Iwashita, In-kyung Park, M. Clarke, S. Morrison (2003)Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation
G. Blobe, W. Schiemann, H. Lodish (2000)Role of transforming growth factor beta in human disease.
The New England journal of medicine, 342 18
M. Smyth, S. Strobl, H. Young, J. Ortaldo, A. Ochoa (1991)Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta.
Journal of immunology, 146 10
J. Massagué, S. Blain, R. Lo (2000)TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
D. Parsons, Siân Jones, Xiaosong Zhang, Jimmy Lin, R. Leary, P. Angenendt, P. Mankoo, H. Carter, I. Siu, G. Gallia, A. Olivi, R. McLendon, B. Rasheed, S. Keir, T. Nikolskaya, Y. Nikolsky, D. Busam, H. Tekleab, L. Diaz, James Hartigan, Douglas Smith, R. Strausberg, S. Marie, S. Shinjo, Hai Yan, G. Riggins, D. Bigner, R. Karchin, N. Papadopoulos, G. Parmigiani, B. Vogelstein, V. Velculescu, K. Kinzler (2008)An Integrated Genomic Analysis of Human Glioblastoma Multiforme
B. Rasheed, R. Wiltshire, S. Bigner, D. Bigner (1999)Molecular pathogenesis of malignant gliomas.
Current opinion in oncology, 11 3
C Arteaga, S Hurd, A Winnier (1993)Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity
J Clin Invest, 92
A. Morén, T. Imamura, K. Miyazono, C. Heldin, A. Moustakas (2005)Degradation of the Tumor Suppressor Smad4 by WW and HECT Domain Ubiquitin Ligases*
Journal of Biological Chemistry, 280
Sheila Singh, C. Hawkins, I. Clarke, J. Squire, J. Bayani, T. Hide, R. Henkelman, M. Cusimano, M. Cusimano, P. Dirks (2004)Identification of human brain tumour initiating cells
Nadia Veilleux, P. Goffaux, M. Boudrias, D. Mathieu, K. Daigle, D. Fortin (2010)Quality of life in neurooncology--age matters.
Journal of neurosurgery, 113 2
SF Louis, BJ Vermolen, Y Garini (2005)c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus
Proc Natl Acad Sci U S A, 102
Hyung-song Nam, R. Benezra (2009)High levels of Id1 expression define B1 type adult neural stem cells.
Cell stem cell, 5 5
D. Gatherer, Peter DUke, D. Baird, R. Akhurst (1990)Expression of TGF-beta isoforms during first trimester human embryogenesis.
Development, 110 2
C. Woiciechowsky, K. Asadullah, D. Nestler, B. Schöning, F. Glöckner, W. Döcke, H. Volk (1998)Diminished monocytic HLA-DR expression and ex vivo cytokine secretion capacity in patients with glioblastoma: Effect of tumor extirpation
Journal of Neuroimmunology, 84
A. Bonni, Yi. Sun, Mireya Nadal-Vicens, Ami Bhatt, D. Frank, I. Rozovsky, N. Stahl, G. Yancopoulos, M. Greenberg (1997)Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway.
Science, 278 5337
R. Stupp, M. Hegi, W. Mason, M. Bent, M. Taphoorn, R. Janzer, S. Ludwin, A. Allgeier, B. Fisher, K. Bélanger, P. Hau, A. Brandes, J. Gijtenbeek, C. Marosi, C. Vecht, K. Mokhtari, P. Wesseling, S. Villà, E. Eisenhauer, T. Gorlia, M. Weller, D. Lacombe, J. Cairncross, R. Mirimanoff (2009)Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
The Lancet. Oncology, 10 5
T. Tsukazaki, T. Chiang, A. Davison, L. Attisano, J. Wrana (1998)SARA, a FYVE Domain Protein that Recruits Smad2 to the TGFβ Receptor
I. Huijbers, M. Iravani, S. Popov, D. Robertson, S. Al-Sarraj, Chris Jones, C. Isacke (2010)A Role for Fibrillar Collagen Deposition and the Collagen Internalization Receptor Endo180 in Glioma Invasion
PLoS ONE, 5
Catherine Gatza, Sun-Young Oh, G. Blobe (2010)Roles for the type III TGF-beta receptor in human cancer.
Cellular signalling, 22 8
Guannan Wang, I. Matsuura, Dongming He, Fang Liu (2009)Transforming Growth Factor-β-inducible Phosphorylation of Smad3*
Journal of Biological Chemistry, 284
Takanori Ebisawa, Minoru Fukuchi, Gyo Murakami, T. Chiba, Keiji Tanaka, T. Imamura, K. Miyazono (2001)Smurf1 Interacts with Transforming Growth Factor-β Type I Receptor through Smad7 and Induces Receptor Degradation*
The Journal of Biological Chemistry, 276
L. Morford, L. Elliott, S. Carlson, W. Brooks, T. Roszman (1997)T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors.
Journal of immunology, 159 9
Xia Lin, M. Liang, Xin-Hua Feng (2000)Smurf2 Is a Ubiquitin E3 Ligase Mediating Proteasome-dependent Degradation of Smad2 in Transforming Growth Factor-β Signaling* 210
The Journal of Biological Chemistry, 275
A. Moustakas, C. Heldin (2005)Non-Smad TGF-β signals
Journal of Cell Science, 118
J. Massagué, D. Wotton (2000)Transcriptional control by the TGF‐β/Smad signaling system
The EMBO Journal, 19
A. Bruna, R. Darken, F. Rojo, A. Ocaña, S. Peñuelas, A. Arias, R. París, A. Tortosa, J. Mora, J. Baselga, J. Seoane (2007)High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.
Cancer cell, 11 2
A. Nakao, T. Imamura, S. Souchelnytskyi, M. Kawabata, A. Ishisaki, E. Oeda, K. Tamaki, J. Hanai, C. Heldin, K. Miyazono, P. Dijke (1997)TGF‐β receptor‐mediated signalling through Smad2, Smad3 and Smad4
The EMBO Journal, 16
Peter Kavsak, R. Rasmussen, C. Causing, S. Bonni, Hai-qing Zhu, G. Thomsen, J. Wrana (2000)Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation.
Molecular cell, 6 6
H. Ikushima, T. Todo, Y. Ino, Masamichi Takahashi, K. Miyazawa, K. Miyazono (2009)Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors.
Cell stem cell, 5 5
S. Bauer, P. Patterson (2006)Leukemia Inhibitory Factor Promotes Neural Stem Cell Self-Renewal in the Adult Brain
The Journal of Neuroscience, 26
K. Plate, G. Breier, H. Weich, W. Risau (1992)Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
Tao Huang, L. David, Valentı́n Mendoza, Yong Yang, Maria Villarreal, K. De, Luzhe Sun, X. Fang, F. López‐Casillas, J. Wrana, A. Hinck (2011)TGF‐β signalling is mediated by two autonomously functioning TβRI:TβRII pairs
The EMBO Journal, 30
Alicia Chung, John Lee, N. Ferrara (2010)Targeting the tumour vasculature: insights from physiological angiogenesis
Nature Reviews Cancer, 10
R. Schlingensiepen, M. Goldbrunner, M. Szyrach, G. Stauder, P. Jachimczak, U. Bogdahn, F. Schulmeyer, P. Hau, K. Schlingensiepen (2005)Intracerebral and intrathecal infusion of the TGF-beta 2-specific antisense phosphorothioate oligonucleotide AP 12009 in rabbits and primates: toxicology and safety.
Oligonucleotides, 15 2
Y. Asano, T. Shibuya, S. Okamura, E. Morioka, S. Taniguchi, Y. Niho (1987)Synergism of leukemic blast growth factors in medium conditioned by human bladder carcinoma cell line 5637.
International journal of cell cloning, 5 6
G. Gomez, M. Varella-Garcia, C. Kruse (2006)Isolation of immunoresistant human glioma cell clones after selection with alloreactive cytotoxic T lymphocytes: cytogenetic and molecular cytogenetic characterization.
Cancer genetics and cytogenetics, 165 2
R. Galli, Elena Binda, U. Orfanelli, B. Cipelletti, A. Gritti, Simona Vitis, R. Fiocco, C. Foroni, F. DiMeco, A. Vescovi (2004)Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
Cancer Research, 64
A. Dix, W. Brooks, T. Roszman, L. Morford (1999)Immune defects observed in patients with primary malignant brain tumors
Journal of Neuroimmunology, 100
D. Louis, H. Ohgaki, O. Wiestler, W. Cavenee, P. Burger, A. Jouvet, B. Scheithauer, P. Kleihues (2007)The 2007 WHO Classification of Tumours of the Central Nervous System
Acta Neuropathologica, 114
D. Beier, J. Schulz, C. Beier (2011)Chemoresistance of glioblastoma cancer stem cells - much more complex than expected
Molecular Cancer, 10
R. Govinden, K. Bhoola (2003)Genealogy, expression, and cellular function of transforming growth factor-beta.
Pharmacology & therapeutics, 98 2
P. Hösli, A. Sappino, N. Tribolet, P. Dietrich (1998)Malignant glioma: should chemotherapy be overthrown by experimental treatments?
Annals of oncology : official journal of the European Society for Medical Oncology, 9 6
A. Bleau, D. Hambardzumyan, T. Ozawa, Elena Fomchenko, J. Huse, C. Brennan, E. Holland (2009)PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.
Cell stem cell, 4 3
Yiwen Jiang, Lene Uhrbom (2012)On the origin of glioma
Upsala Journal of Medical Sciences, 117
U. Bogdahn, P. Hau, G. Stockhammer, N. Venkataramana, A. Mahapatra, A. Suri, A. Balasubramaniam, S. Nair, V. Oliushine, V. Parfenov, I. Poverennova, M. Zaaroor, P. Jachimczak, S. Ludwig, S. Schmaus, H. Heinrichs, K. Schlingensiepen (2010)Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
A. Lassman, C. Dai, G. Fuller, A. Vickers, E. Holland (2004)Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice.
Neuron glia biology, 1 2
Degui Wang, H. Huang, A. Kazlauskas, W. Cavenee (1999)Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase.
Cancer research, 59 7
A. Facoetti, F. Pasi, R. Nano (2010)Some considerations for the study of TGFbeta in medium of irradiated T98G cells: activation, release and consumption.
Anticancer research, 30 9
Ruey-Hwa Chen, R. Ebner, R. Derynck (1993)Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities.
Science, 260 5112
Q. Yu, I. Stamenkovic (2000)Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis.
Genes & development, 14 2
R. Stupp, Warren Mason, M. Bent, M. Weller, B. Fisher, M. Taphoorn, K. Bélanger, A. Brandes, C. Marosi, U. Bogdahn, J. Curschmann, Robert Janzer, Samuel Ludwin, T. Gorlia, A. Allgeier, D. Lacombe, J. Cairncross, E. Eisenhauer, R. Mirimanoff (2005)Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
The New England journal of medicine, 352 10
M. Uhl, Steffen Aulwurm, J. Wischhusen, M. Weiler, J. Ma, R. Almirez, R. Mangadu, Yu-Wang Liu, M. Platten, U. Herrlinger, Alison Murphy, Darren Wong, W. Wick, L. Higgins, M. Weller (2004)SD-208, a Novel Transforming Growth Factor β Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma Cells In vitro and In vivo
Cancer Research, 64
M. Clarke, J. Dick, P. Dirks, C. Eaves, C. Jamieson, D. Jones, J. Visvader, I. Weissman, G. Wahl (2006)Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.
Cancer research, 66 19
M. Marchetto, C. Carromeu, Allan Acab, Diana Yu, Gene Yeo, Yangling Mu, Gong Chen, F. Gage, A. Muotri (2010)A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells
Mengxian Zhang, S. Kleber, M. Röhrich, C. Timke, N. Han, J. Tuettenberg, A. Martin-Villalba, J. Debus, Peter, Peschke, U. Wirkner, M. Lahn, P. Huber (2011)Blockade of TGF-beta signaling by the TGF β R-I kinase Inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma
H Ikushima, T Todo, Y Ino (2009)Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors
Stem Cell, 5
Jonathan Sims, S. Ganguly, Holly Bennett, J. Friend, J. Tepe, R. Plattner (2013)Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-κB and HSP27/p38/AKT Pathways and by Inhibiting ABCB1
PLoS ONE, 8
Jui-Chang Tsai, C. Goldman, G. Gillespie (1995)Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF.
Journal of neurosurgery, 82 5
Libing Song, Liping Liu, Zhiqiang Wu, Yun Li, Zhe Ying, Chuyong Lin, Jueheng Wu, Bo Hu, Shi-Yuan Cheng, Mengfeng Li, Jun Li (2012)TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets.
The Journal of clinical investigation, 122 10
B. Lowin-Kropf, V. Shapiro, A. Weiss (1998)Cytoskeletal Polarization of T Cells Is Regulated by an Immunoreceptor Tyrosine-based Activation Motif–dependent Mechanism
The Journal of Cell Biology, 140
M. Platten, Wolfgang Wick, M. Weller (2001)Malignant glioma biology: Role for TGF‐β in growth, motility, angiogenesis, and immune escape
Microscopy Research and Technique, 52
L. Wakefield, A. Roberts (2002)TGF-β signaling: positive and negative effects on tumorigenesis
Current Opinion in Genetics & Development, 12
J. Folkman (1995)Angiogenesis in cancer, vascular, rheumatoid and other disease
Nature Medicine, 1
P. Walker, T. Calzascia, P. Dietrich (2002)All in the head: obstacles for immune rejection of brain tumours
H. Phillips, S. Kharbanda, Ruihuan Chen, W. Forrest, R. Soriano, Thomas Wu, A. Misra, J. Nigro, H. Colman, L. Soroceanu, P. Williams, Z. Modrušan, B. Feuerstein, K. Aldape (2006)Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.
Cancer cell, 9 3
Yu-an Yang, O. Dukhanina, Binwu Tang, M. Mamura, J. Letterio, J. Macgregor, S. Patel, S. Khozin, Zi-yao Liu, Jeffrey Green, M. Anver, G. Merlino, L. Wakefield (2002)Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects.
The Journal of clinical investigation, 109 12
D. Silbergeld, M. Chicoine (1997)Isolation and characterization of human malignant glioma cells from histologically normal brain.
Journal of neurosurgery, 86 3
Thomas Inge, S. Hoover, Brian Susskind, S. Barrett, Harry Bear (1992)Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
Cancer research, 52 6
B. Brooks, K. Chapman, John Lawry, Anthony Meager, Robert Rees (1990)Suppression of lymphokine‐activated killer (LAK) cell induction mediated by interleukin‐4 and transforming growth factor‐β1: effect of addition of exogenous tumour necrosis factor‐alpha and interferon‐gamma, and measurement of their endogenous production
Clinical & Experimental Immunology, 82
Long Zhang, Fangfang Zhou, Yvette Drabsch, Rui Gao, B. Snaar-Jagalska, C. Mickanin, Huizhe Huang, K. Sheppard, Jeff Porter, Chris Lu, P. Dijke (2012)USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor
Nature Cell Biology, 14
M. Friese, J. Wischhusen, W. Wick, M. Weiler, G. Eisele, Alexander Steinle, M. Weller (2004)RNA Interference Targeting Transforming Growth Factor-β Enhances NKG2D-Mediated Antiglioma Immune Response, Inhibits Glioma Cell Migration and Invasiveness, and Abrogates Tumorigenicity In vivo
Cancer Research, 64
S. Dupont, A. Mamidi, M. Cordenonsi, Marco Montagner, L. Zacchigna, M. Adorno, Graziano Martello, Michael Stinchfield, S. Soligo, Leonardo Morsut, M. Inui, S. Moro, N. Modena, F. Argenton, S. Newfeld, S. Piccolo (2009)FAM/USP9x, a Deubiquitinating Enzyme Essential for TGFβ Signaling, Controls Smad4 Monoubiquitination
P. Hau, P. Jachimczak, R. Schlingensiepen, F. Schulmeyer, T. Jauch, A. Steinbrecher, A. Brawanski, M. Proescholdt, J. Schlaier, J. Buchroithner, J. Pichler, G. Wurm, M. Mehdorn, R. Strege, G. Schuierer, V. Villarrubia, F. Fellner, O. Jansen, T. Straube, V. Nohria, M. Goldbrunner, M. Kunst, S. Schmaus, G. Stauder, U. Bogdahn, K. Schlingensiepen (2007)Inhibition of TGF-β2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies
W. Kavanaugh, G. Harsh, N. Starksen, C. Rocco, L. Williams (1988)Transcriptional regulation of the A and B chain genes of platelet-derived growth factor in microvascular endothelial cells.
The Journal of biological chemistry, 263 17
K. Quattrocchi, Claramae Miller, S. Cush, S. Bernard, S. Dull, Michelle Smith, S. Gudeman, M. Varia (2004)Pilot Study of Local Autologous Tumor Infiltrating Lymphocytes for the Treatment of Recurrent Malignant Gliomas
Journal of Neuro-Oncology, 45
J. Anido, A. Sáez-Borderías, Alba Gonzàlez-Juncà, L. Rodón, Gerard Folch, Maria Carmona, Rosa Prieto-Sánchez, I. Barba, E. Martínez-Sáez, L. Prudkin, I. Cuartas, C. Raventós, F. Martínez-Ricarte, M. Poca, D. Garcia-Dorado, M. Lahn, J. Yingling, J. Rodón, J. Sahuquillo, J. Baselga, J. Seoane (2010)TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma.
Cancer cell, 18 6
H. Newton, Mary Slivka, C. Volpi, E. Bourekas, G. Christoforidis, M. Baujan, W. Slone, D. Chakeres (2004)Intra-arterial Carboplatin and Intravenous Etoposide for the Treatment of Metastatic Brain Tumors
Journal of Neuro-Oncology, 61
J Folkman, M Klagsbrun (1987)Angiogenic factors
Q. Ostrom, H. Gittleman, Peter Liao, Chaturia Rouse, Yanwen Chen, J. Dowling, Yingli Wolinsky, C. Kruchko, J. Barnholtz-Sloan (2012)CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.
Neuro-oncology, 16 Suppl 4
Jay Turner, A. Abla, N. Sanai (2012)Identification of the glioma cell of origin.
World neurosurgery, 78 3-4
Masayoshi Horimoto, Junji Kato, R. Takimoto, T. Terui, Y. Mogi, Yoshiro Niitsu (1995)Identification of a transforming growth factor beta-1 activator derived from a human gastric cancer cell line.
British Journal of Cancer, 72
H. Rooprai, Garry Rucklidge, C. Panou, G. Pilkington (1999)The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells
British Journal of Cancer, 82
G. Fròsina (2009)DNA Repair and Resistance of Gliomas to Chemotherapy and Radiotherapy
Molecular Cancer Research, 7
W. Wick, M. Plattén, M. Weller (2001)Glioma Cell Invasion: Regulation of Metalloproteinase Activity by TGF-β
Journal of Neuro-Oncology, 53
W. Brooks, T. Roszman, M. Mahaley, R. Woosley (1977)Immunobiology of primary intracranial tumours. II. Analysis of lymphocyte subpopulations in patients with primary brain tumours.
Clinical and experimental immunology, 29 1
C. Arteaga, S. Hurd, A. Winnier, M Johnson, B Fendly, J Forbes (1993)Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
The Journal of clinical investigation, 92 6
TA Dolecek, JM Propp, NE Stroup (2012)CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005?2009
Neurol Oncol, 14
G. Desmarais, D. Fortin, R. Bujold, R. Wagner, D. Mathieu, B. Paquette (2012)Infiltration of glioma cells in brain parenchyma stimulated by radiation in the F98/Fischer rat model
International Journal of Radiation Biology, 88
A. Wilczewska, K. Niemirowicz, K. Markiewicz, H. Car (2012)Nanoparticles as drug delivery systems
Pharmacological Reports, 64
T Huang, L David, V Mendoza (2011)TGF-beta; signaling is mediated by two autonomously functioning TBRI:TBRII pairs
EMBO J, 30
T. Schneider, M. Sailer, S. Ansorge, R. Firsching, D. Reinhold (2006)Increased concentrations of transforming growth factor β1 and β2 in the plasma of patients with glioblastoma
Journal of Neuro-Oncology, 79
M. Jennings, J. Pietenpol (2004)The role of transforming growth factor Β in glioma progression
Journal of Neuro-Oncology, 36
G. Thomas (2002)Furin at the cutting edge: From protein traffic to embryogenesis and disease
Nature Reviews Molecular Cell Biology, 3
W. Pardridge (2007)Blood-brain barrier delivery of protein and non-viral gene therapeutics with molecular Trojan horses.
Journal of controlled release : official journal of the Controlled Release Society, 122 3
Seema Ahuja, F. Paliogianni, Hidehiro Yamada, James Balow, Dimitrios Boumpas (1993)Effect of transforming growth factor-beta on early and late activation events in human T cells.
Journal of immunology, 150 8 Pt 1
R. Ueda, M. Fujita, Xinmei Zhu, Kotaro Sasaki, Edward Kastenhuber, G. Kohanbash, Heather McDonald, Jay Harper, S. Lonning, H. Okada (2009)Systemic Inhibition of Transforming Growth Factor-β in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines
Clinical Cancer Research, 15
J. Tonn, S. Kerkau, A. Hanke, H. Bouterfa, J. Mueller, S. Wagner, G. Vince, K. Roosen (1999)Effect of synthetic matrix‐metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas In vitro
International Journal of Cancer, 80
M. Pepper (1997)Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity.
Cytokine & growth factor reviews, 8 1
W. Hickey (2001)Basic principles of immunological surveillance of the normal central nervous system
H. Hayashi, S. Abdollah, Yubin Qiu, Jie Cai, Yong-Yao Xu, B. Grinnell, M. Richardson, J. Topper, M. Gimbrone, J. Wrana, D. Falb (1997)The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling
K. Schlingensiepen, R. Schlingensiepen, A. Steinbrecher, P. Hau, U. Bogdahn, Birgit Fischer‐Blass, P. Jachimczak (2006)Targeted tumor therapy with the TGF-β2 antisense compound AP 12009
Cytokine & Growth Factor Reviews, 17
D. Clark, RK Coker (1998)Transforming growth factor-beta (TGF-beta).
The international journal of biochemistry & cell biology, 30 3
Akio Suzumura, Makoto Sawada, H. Yamamoto, T. Marunouchi (1993)Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro.
Journal of immunology, 151 4
Chong Liu, J. Sage, Michael Miller, R. Verhaak, Simon Hippenmeyer, H. Vogel, O. Foreman, R. Bronson, A. Nishiyama, L. Luo, H. Zong (2011)Mosaic Analysis with Double Markers Reveals Tumor Cell of Origin in Glioma
M. Inui, A. Manfrin, A. Mamidi, Graziano Martello, Leonardo Morsut, S. Soligo, E. Enzo, S. Moro, Simona Polo, S. Dupont, M. Cordenonsi, S. Piccolo (2011)USP15 is a deubiquitylating enzyme for receptor-activated SMADs
Nature Cell Biology, 13
M. Hardee, A. Marciscano, Christina Medina-Ramirez, D. Zagzag, A. Narayana, S. Lonning, M. Barcellos-Hoff (2012)Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β.
Cancer research, 72 16
Ying Zhang (2009)Non-Smad pathways in TGF-β signaling
Cell Research, 19
R. Derynck, Ying Zhang (2003)Smad-dependent and Smad-independent pathways in TGF-β family signalling
D. Constam, J. Philipp, U. Malipiero, P. Dijke, M. Schachner, A. Fontana (1992)Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblastoma cells, astrocytes, and microglia.
Journal of immunology, 148 5
S Abdollah, M Marcias-Silva, T Tsukazaki (1997)TBRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and
J Biol Chem, 272
M. Gow, C. Seymour, L. Ryan, C. Mothersill (2010)Induction of Bystander Response in Human Glioma Cells using High-Energy Electrons: A Role for TGF-β1
J. Rich, D. Bigner (2004)Development of novel targeted therapies in the treatment of malignant glioma
Nature Reviews Drug Discovery, 3
P. Eichhorn, L. Rodón, Alba Gonzàlez-Juncà, A. Dirac, M. Gili, E. Martínez-Sáez, C. Aura, I. Barba, V. Peg, A. Prat, I. Cuartas, J. Jiménez, D. Garcia-Dorado, J. Sahuquillo, R. Bernards, J. Baselga, J. Seoane (2012)USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma
Nature Medicine, 18
G. Gomez, C. Kruse (2006)Mechanisms of malignant glioma immune resistance and sources of immunosuppression.
Gene therapy & molecular biology, 10 A
S. Frank, M. Nowak (2003)Cell biology: Developmental predisposition to cancer
D. Fortin (2012)The blood-brain barrier: its influence in the treatment of brain tumors metastases.
Current cancer drug targets, 12 3
C. Kjellman, S. Olofsson, O. Hansson, T. Schantz, M. Lindvall, I. Nilsson, L. Salford, H. Sjögren, B. Widegren (2000)Expression of TGF‐β isoforms, TGF‐β receptors, and SMAD molecules at different stages of human glioma
International Journal of Cancer, 89
H. Fakhrai, O. Dorigo, D. Shawler, Hong Lin, D. Mercola, K. Black, I. Royston, R. Sobol (1996)Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy.
Proceedings of the National Academy of Sciences of the United States of America, 93 7
C. Crane, S. Han, Jeffery Barry, Brian Ahn, L. Lanier, A. Parsa (2010)TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients.
Neuro-oncology, 12 1
S. Bigner, J. Mark, D. Bullard, M. Mahaley, D. Bigner (1986)Chromosomal evolution in malignant human gliomas starts with specific and usually numerical deviations.
Cancer genetics and cytogenetics, 22 2
Sheila Singh, I. Clarke, Mizuhiko Terasaki, Victoria Bonn, C. Hawkins, J. Squire, P. Dirks (2003)Identification of a cancer stem cell in human brain tumors.
Cancer research, 63 18
J. Xu, L. Attisano (2000)Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
Proceedings of the National Academy of Sciences of the United States of America, 97 9
Mengxian Zhang, Tobias Herion, C. Timke, N. Han, Kai Hauser, K. Weber, P. Peschke, U. Wirkner, M. Lahn, P. Huber (2011)Trimodal glioblastoma treatment consisting of concurrent radiotherapy, temozolomide, and the novel TGF-β receptor I kinase inhibitor LY2109761.
Neoplasia, 13 6
Malignant gliomas are the most common type of primary malignant brain tumors. They are characterized by enhanced growing capabilities, neoangiogenic proliferation, and extensive infiltration of the brain parenchyma, which make their complete surgical resection impossible. Together with transient and refractory responses to standard therapy, these aggressive neoplasms are incurable and present a median survival of 12 to 14 months. Transforming growth factor-beta (TGF-β) is a pleiotropic cytokine of which two of the three isoforms expressed in humans have been shown to be overexpressed proportionally to the histologic grade of glioma malignancy. The increase of chromosomal aberrations and genetic mutations observed in glioma cells turns TGF-β into an oncogene. For that reason, it plays critical roles in glioma progression through induction of several genes implicated in many carcinogenic processes such as proliferation, angiogenesis, and invasion. Consequently, investigators have begun developing innovative therapeutics targeting this growth factor or its signaling pathway in an attempt to hinder TGF-β’s appalling effects in order to refine the treatment of malignant gliomas and improve their prognosis. In this paper, we extensively review the TGF-β-induced oncogenic pathways and discuss the diverse new molecules targeting this growth factor.
Targeted Oncology – Springer Journals
Published: Mar 5, 2014
Access the full text.
Sign up today, get DeepDyve free for 14 days.